Australia Healthcare Diagnostics Market

1. A sample report on Australia Healthcare Diagnostics Market Analysis

2. This report presents a strategic analysis of the Australia Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Australia Healthcare Diagnostics Market, and offers unmatched value, accuracy, and expert insights.

3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2022 Forecast Period 2023-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Billion (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

4. Table of Content CONTENT PG. NO. 12-25 1. Healthcare Diagnostics Overview 1.1. Overview 1.2. Australia Overview 1.3. Economic Overview: Australia 1.4. Statistic at a glance 1.5. Healthcare Services Market in Australia 1.6. Healthcare Scenario in Australia 1.7. Health Insurance Coverage: Australia 1.8. Budget of the Government for Public Insurance 1.9. Mergers and Acquisitions 26-31 2. Market Size and Forecasting 2.1 Market size and forecasts (Excel and Methodology) 2.2. Market Segmentation 4 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

5. Table of Content CONTENT PG. NO. 2.2.1. By Test 2.2.2. By Testing Method 2.2.3. By End User 32-36 3. Types of Clinical Diagnostics Test 3.1 Laboratory Test 3.2 Imaging Test 3.3 Point-Of-Care Testing 37-41 4. Market Dynamics 4.1. Market Growth Drivers 4.1.1. Increasing Prevalence of Health Morbidities like Cancer, Chronic & Infectious Diseases 4.1.2. Growing awareness about early detection & screening of diseases 4.1.3. Government initiatives and investments in increasing number of equipment in diagnostic facility 5 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

6. Table of Content CONTENT PG. NO. 4.2. Market Restraints 4.2.1. Delayed in Diagnosis 4.2.2. Shortage of Diagnosis Equipment 42-47 4.2.3. Data Privacy Concerns 5. Competitive Landscape 5.1. Key Company Profile 5.1.1. Australia Clinical Labs 48-54 6. Reimbursement Scenario 6.1. Reimbursement Regulation 6.2. Reimbursement Process for Diagnosis 6.3 Reimbursement Process – Medicare 6.4 Reimbursement Process – Medicaid 6 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

7. Table of Content CONTENT PG. NO. 55-62 7. Methodology & Scope 7 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

8. Australia Healthcare Diagnostics Market Analysis 1. Healthcare Diagnostics Overview

9. 1.1 Statistics at a Glance: Status of Healthcare Diagnostics in the World Overview of Healthcare Diagnostics Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ $76.2 Bn Was the market size of Global Clinical Diagnostics in 2022 8.56% Can be the exhibiting CAGR of the Clinical Diagnostics Market from 2022-2028 In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ 17-20% Is the expected increase in revenue of the diagnostic companies 55% Of the most downloaded clinically rated apps are linked to biosensors In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ $7 Bn/year Is the amount saved using the health apps by monitoring and diagnosing health condition associated with diabetes prevention and care, asthma, and cardiac and pulmonary rehabilitation Illustrative Illustrative 9 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

10. 1.1 Statistics at a Glance: The Status of Healthcare Diagnostics in the World (continued) Europe ~Revenue to reach $XX Bn by 2027 North America ~ Market Size of $XX Bn Asia -Fastest CAGR Australia Market ~$xx Mn Market Africa ~Market Size of $XX Bn Illustrative Illustrative 10 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

11. 1.2 Australia Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ 25.7 Mn Is the population of Australia, in 2021 $1.55 Tn Is the Gross Domestic Product (GDP) in Australia in 2021 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 38.5 years Is the median age in Australia, in 2022 $8617 per capita was the amount of national health expenditures in 2021 Illustrative Illustrative 11 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

12. 1.3 Economic Overview: Australia Population of Australia, (2020-2030) GDP of Australia, (2020-2030) XX XX XX XX 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 0-14 15-24 25-54 Male 49% Female 51% Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 55-64 65+ Illustrative Illustrative 12 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

13. 1.4 Statistics at a Glance: Glance at Australia Healthcare Diagnostics Market Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ $827 Mn Was the market size of Australia Clinical Diagnostics Market in 2022 7.5% Is the expected CAGR of the Australia Clinical Diagnostics Market for period of 2022- 2030 In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic in Australia ▪ 2,808 Is the number of medical and diagnostic laboratory companies are present in Australia 42 days Is the average waiting period for CT scans in Australia In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 13 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

14. 1.5 Healthcare Services in Australia Australia Healthcare Services Market Forecast, 2022-2030 (in $Bn) xx xx xx xx xx xx xx xx xx 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall Healthcare Services market in Australia, which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 14 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

15. 1.6 Healthcare Scenario in Australia Healthcare scenario in Australia is characterized by a robust system that aims to provide universal access to high- quality healthcare services Universal Healthcare: Australia has a universal healthcare system known as Public. It provides Australians with access to subsidized medical services, including visits to general practitioners, specialist consultations, and public hospital services. 1. Primary Healthcare: Primary healthcare plays a vital role in Australia's healthcare system. It involves general practitioners (GPs) who serve as patients’ first point of contact. GPs provide preventive care, diagnose and treat common illnesses, and refer patients to specialists when needed. 2. Public and Private Healthcare: Australia has a mix of public and private healthcare sectors. Public hospitals are funded by the government and provide free or low-cost services to eligible patients. Private healthcare offers additional services and options for those who have private health insurance. 3. Pharmaceutical Benefits Scheme (PBS): The PBS subsidizes the cost of prescription medications, making them more affordable for Australians. Under this scheme, patients pay a reduced price for medications listed on the PBS schedule. 4. Aged Care Services: Australia has a well-developed aged care sector to cater to the needs of older adults. It includes residential aged care facilities, home care services, and community-based programs. 5. Health Workforce: Australia has a well-trained and diverse healthcare workforce, including doctors, nurses, allied health professionals, and specialists. The country also welcomes international healthcare professionals to address workforce needs. 6. Illustrative Illustrative 15 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

16. 1.6 Healthcare Scenario in Australia (continued) Healthcare scenario in Australia is characterized by a robust system that aims to provide universal access to high- quality healthcare services Health Promotion and Prevention: Australia emphasizes health promotion and disease prevention initiatives. Various campaigns and programs focus on promoting healthy lifestyles, disease screening, immunization, and early intervention. 7. Digital Health: The adoption of digital health technologies is increasing in Australia. Electronic health records, telehealth services, and digital health platforms are being used to improve access to healthcare and enhance coordination of care. 8. Illustrative Illustrative 16 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

17. 1.6 Healthcare Scenario: Diagnostic Process Patient Journey Patient sees family doctor or specialist Results get sent to pathologist/ radiologist for review and analysis Physician sends patient for medical imaging Patient Laboratory Test/Imaging Test/Molecular Diagnostic Next Step Based on the radiologist's report, the referring physician decides on the next steps for patient Pathologist/Radiologist Report contains summary of findings, possible diagnoses, and recommended next steps Pathologist/Radiologist produces a report and sends it to referring physician Physician Illustrative Illustrative 17 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

18. 1.7 Health Insurance Coverage: Australia % of People by Type of Health Insurance Coverage (2021) Number of People By Health Insurance Coverage Coverage Type 2020 2021 Change % 8.3 Uninsured Total 327,521 328,074 91.7 With health insurance Any health plan 299,230 300,887 0.4 Any private plan 217,896 216,366 –0.6 66.0 Any private plan Employment-based 178,737 178,285 –0.2 54.3 Employment-based Direct-purchase 33,869 33,555 –0.1 10.2 Direct-purchase Marketplace coverage 10,924 11,389 0.1 3.5 Marketplace TRICARE 9,165 8,299 –0.3 2.5 TRICARE Any public plan 112,925 117,095 1.2 58,541 60,226 0.5 35.7 Any public plan 18.4 Medicare 58,778 61,940 0.9 18.9 Medicaid VA and CHAMPVA 2,967 3,151 0.1 1.0 VA and CHAMPVA Uninsured 28,291 27,187 –0.4 In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year More people had private health insurance (66%) than public coverage (35.7%) Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Public (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%) ▪ ▪ ▪ Illustrative Illustrative 18 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

19. 1.8 Budget of Australia Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 Medicare In Billions Of Dollars $458 $521 $571 $582 $616 $645 $674 $698 $734 $768 $801 $837 $6,926 Private 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% Medicare As % Of GDP 2.2% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.4% 2.5% 2.5% 2.5% 2.5% 2.4% Private National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE ▪ Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 19 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

20. 1.9 Mergers and Acquisitions RCM M&A Deal Value Trend ($Bn) RCM M&A Deal Volume Trend $16.7 112 110 107 107 89 82 $11.7 $10.5 $7.7 $6.8 $6.0 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 1H 2020 2H 2020 1H 2021 2H 2021 1H 2022 2H 2022 Buyer Composition: Strategic Vs Financial (2020) Buyer Type by Deal Size ($Mn) 39% 41% 41% 42% 58% 59% 59% 61% Strategic Buyers Financial Buyers $0- $25 $25-$50 $50-$100 $100+ 57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020 Illustrative Illustrative 20 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

21. 1.9 Mergers and Acquisitions (continued) Latest Deals In Australia Merger/acquisition Company Key Insights In 2019, Siemens Healthineers completed the acquisition of Diagnostic Solutions, a specialized company in cancer screening and diagnostic solutions Objective of this acquisition was to enhance Siemens Healthineers' footprint in the diagnostics market ▪ Acquisition ▪ In August 2023, Australian Clinical Labs (ACL) and Healius revealed plans for a potential merger. ▪ Merger Illustrative Illustrative 21 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

22. 1.9 Mergers and Acquisitions (continued) Latest Deals In Australia Merger/acquisition Company Key Insights Illustrative Illustrative 22 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

23. Australia Healthcare Diagnostics Market Analysis 2. Market Size and Forecasting

24. 2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the methodology and assumption Australia Healthcare Diagnostics Market Forecast, 2022-2030 (in $Bn) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ XX XX In this section you will get an understanding of the overall Healthcare Insurance market in Australia, which includes the market size, current trends and other details related to the topic ▪ 2022 2023F 2024F 2025F 2026F 2025 2027F 2026 2028F 2027 2029F 2030F 2023 2024 2028 2029 2030 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Major Markets Patient (Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Australia Patient Size (Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ % of Australian Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size (Bn $) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Australia Market Size (Bn $) 61 74 84 87 91 95 99 106 Illustrative Illustrative 24 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

25. 2.2 Snapshot of Healthcare Diagnostics Market Segmentation By Test By Testing Methods By End-User Lipid Panel Laboratory Patients Liver Panel Imaging Healthcare Providers Renal Panel Point-of-care Clinical Laboratory Complete Blood Count Hospital & Healthcare institution Electrolyte Testing Others Infectious Disease Testing Others In this section you will get an understanding of the segmentations which will cover the Australia Healthcare Diagnostics Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Illustrative Illustrative 25 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

26. 2.2.1 Market Segmentation: By Test Australia Healthcare Diagnostics Market Share, By Test (2022) Lipid Panel market in Australia is a significant component of the overall clinical diagnostics treatment market ▪ Others Infectious Disease Testing It has the maximum market share in Australia clinical diagnostics market with approximately xx% ▪ Electrolyte Testing Lipid Panel Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Complete Blood Count In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Renal Panel Liver Panel Illustrative Illustrative 26 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

27. 2.2.2 Market Segmentation: By Product Australia Healthcare Diagnostics Market Share, By Testing Methods (2022) Instruments clinical diagnostics market in Australia is a significant component of the overall clinical diagnostics market ▪ It has the maximum market share in Australia clinical diagnostics market with approximately xx% ▪ Point-of-care Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Laboratory In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Imaging Illustrative Illustrative 27 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

28. 2.2.3 Market Segmentation: By End User Australia Healthcare Diagnostics Market Share, By End User (2022) Hospital Laboratories have the maximum market share in Australia clinical diagnostics market with approximately xx% ▪ Patient Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Other Clinical Laboratory In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Healthcare Providers Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Hospital & Healthcare Institution Illustrative Illustrative 28 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

29. Australia Healthcare Diagnostics Market Analysis 3. Types of Healthcare Diagnostics Testing Methods

30. 3.1 Laboratory Test Top most commonly ordered laboratory tests in Australia Community Inpatient Emergency Complete blood count Chem panel 7 Complete blood count Electrolyte panel Complete blood count Creatinine Thyroid stimulating hormone Electrolyte panel Creatinine Magnesium Creatinine Electrolyte panel Alanine amino-transferase Hemoglobin A1c Phosphate Scan with morphology Liver panel Troponin-T LDL cholesterol Ferritin Urea Prothrombin time (INR) Prothrombin time (INR) Urinalysis with microscopic Urinalysis with microscopic Others Calcium Others Blood culture Others The data presented here includes over 51 commonly ordered laboratory tests by percentage in Australia (Appendix 3) Illustrative Illustrative 30 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

31. 3.2 Imaging Test Imaging tests in Australia include: X-rays, CT (Computed Tomography) scans, MRI (Magnetic Resonance Imaging) scans Ultrasound, PET (Positron Emission Tomography) scans, Nuclear imaging & Mammogram ▪ In 2022, it was estimated that 28,600 Canadian women will be diagnosed with breast cancer ultimately raising the demand for Mammography Imaging as well as services ▪ In August 2022, through a collaboration with Synthesis Health, Pelican Narrows and two additional Peter Ballantyne Cree Nation (PBCN) towns, Deschambault Lake and Southend, the first ultra portable X-ray equipment was installed in Australia ▪ Number of diagnostics expected to be performed in Australia (in Mn) Imaging Test 2017 2020 2030 Computed Tomography Scan (CT) in Mn XX XX XX Magnetic Resonance Imaging (MRI) in Mn XX XX XX Positron Emission Tomography (PET) in Mn XX XX XX Illustrative Illustrative 31 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

32. 3.3 Point-Of-Care Testing POC Diagnostics Market Share, By Indication Key Insights Increased prevalence of diabetes and cancer, the use of novel point-of-care diagnostics, and the preference for at-home glucose testing all contribute to the expansion of the blood glucose monitoring market XX% of the population of Australia, or more than XX Mn people, have diabetes, and after accounting for population ageing over time, the prevalence has been rising at an average rate of XX% each year Considerable risk of acquiring type 2 diabetes is also posed by the XX% prevalence of prediabetes in Canadian adults On the other side, the category for infectious disorders is expected to develop at the quickest rate Market segment for infectious diseases is anticipated to expand significantly over the forecast period due to the rising prevalence of various infectious disorders ▪ Hematology Testing Cardiometabolic Diseases ▪ Others Pregnancy & Infertility Testing ▪ Infectious Diseases ▪ Blood Glucose Monitoring ▪ Other*- Hyperthyroidism, Oxygen Testing, assessment for developing contrast- induced nephropathy (CIN), Colorectal cancer screening, Dipstick urinalysis Illustrative Illustrative 32 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

33. Australia Healthcare Diagnostics Market Analysis 4. Market Dynamics

34. 4.1 Market growth drivers 4.1.1 Increasing Prevalence of Health Morbidities like Cancer, Chronic & Infectious Diseases. 46.6% of population have at least 1 of 10 common chronic conditions in Australia Incidence of Diseases in Australia Incidence of diseases is increasing in Australia, In 2021, approximately 151,000 new instances of cancer were identified in Australia. ▪ Nearly half of Australians, spanning all age groups (46.6%), experienced one or more chronic conditions, with nearly one in five individuals (18.6%) grappling with two or more chronic health issues. ▪ This is driving the demand for clinical diagnostics treatments and creating opportunities for growth in the clinical diagnostics market ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 34 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

35. 4.1 Market growth drivers (continued) 4.1.2 Growing awareness about early detection & screening of diseases. The Australian government has established nationwide screening initiatives for breast, cervical, and bowel cancers Top countries that are leveraging technology in their fight against healthcare diagnostics Primary goal of these screening programs is to enhance public health outcomes by minimizing the impact of illness and mortality associated with these cancers through early detection and timely intervention ▪ Norway Austria QAAMS pathology program is designed to offer prompt on- site diabetes testing specifically for Aboriginal and Torres Strait Islander individuals residing in rural and remote areas ▪ Denmark Belgium Spain Italy Netherlands In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Sweden Singapore Switzerland Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Israel Australia Canada France United Kingdom China South Korea Germany Japan United States Illustrative Illustrative 35 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

36. 4.1 Market growth drivers (continued) 4.1.3 Government initiatives and investments in increasing number and quality of equipment in diagnostic facility. Australia government provides significant support and funding for clinical diagnostics research and treatment, which is driving innovation and growth in the clinical diagnostics market ▪ Fundings from government and other organizations Source Year Fund ($) Albanese Government is allocating $XX Mnto support XX projects focused on providing educational initiatives for healthcare professionals and the public ▪ Replacing Outdated Equipment XX $ XX Mn These programs aim to enhance awareness about the appropriate utilization of medicines and diagnostic technologies ▪ Lund disease scanner XX $ XX Mn Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Digital health XX $ XX Mn In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Albanese Government XX $ XX Mn Illustrative Illustrative 36 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

37. 4.2 Market restraints 3.2.3 Data Privacy Concerns. Approximately 75% of Australians believe that data breaches pose one of the most significant privacy threats they encounter in the present day 3.2.2 Australia's clinical diagnostics sector operates under rigorous regulations, featuring strict standards for the approval of products and ongoing quality monitoring 3.2.1 High cost & Delayed in Diagnosis. 30% of Australian children with rare disease waited for 5 or more years for diagnosis Medicare breach reported in October 2022 was among the most recent incidents that profoundly impacted the industry, revealing the sensitive data of 9.7 Mn existing and former customers Clinical diagnostics treatments can be very expensive and can lead to financial burden for patients and healthcare systems ▪ ▪ Requirements for clinical diagnostics treatments can be very stringent, which can slow down the approval process and limit access to new treatments ▪ Cost of clinical diagnostics treatment varies depending on the type of clinical diagnostics, stage of clinical diagnostics, and treatment options ▪ Therapeutic Goods Administration (TGA) is the regulatory authority overseeing medical devices, including in vitro diagnostic medical devices, in Australia ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Some common clinical diagnostics treatments, such as chemotherapy and radiation therapy, can cost tens of thousands of dollars ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Manufacturers and sponsors of medical devices are obligated to adhere to the mandatory requirements and fulfill ongoing responsibilities as stipulated by the TGA ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 37 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

38. Australia Healthcare Diagnostics Market Analysis 5. Competitive Landscape

39. 5.1 Key Company Profile Service Providers Manufacturers Key Note: Here is the list of top 10 companies which will cover in the final report ▪ 1 Australian Clinical Labs 6 AusDiagnostics Each company will have slides for ▪ Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative Illustrative o 2 Healius Healthcare o o o 7 Abbott 3 Sonic Healthcare o o 8 Bio-Rad Laboratories, Inc o 4 Austech Medical Laboratories o ▪ 9 Roche 5 Healthcscope Limited ▪ 10 Siemens 39 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

40. 5.1.1 Australian Clinical Labs (ACL) Solutions offered by ACL ▪ Australian Clinical Labs stands as a prominent private pathology services provider in Australia, with 75 laboratories accredited by NATA, offering essential diagnostic services ▪ Annually, our accredited laboratories conduct more than 12 million tests, benefiting both healthcare professionals and individuals within the local communities we serve ▪ As a leading entity in the field, Australian Clinical Labs plays a vital role in delivering high-quality pathology services to clinicians and patients across Australia Founded in: 2015 ➢ Diagnostics HQ: Sydney, Australia ➢ Pharmacogenetic Testing Type: Private Revenue: $995.6 Mn ➢ Hospital Services Website: Australian Clinical Labs ➢ Courier Service Services Offered Recent Activity / Press Coverage Advanced molecular genetics testing Routine pathology tests › Australian Clinical Labs (ACL) parent company Medlab faced a Quantum hacking group cyber attack in February 2022, resulting in the theft of 86GB data from over 200,000 people, including health, passport, and credit card details Harmony NIPT & first trimester screening Genetic carrier screening Pharmacogenomic Tests Allergy & immunology › Geneseq Biosciences and Australian Clinical Labs have declared their collaboration to introduce the inaugural non-invasive melanoma test to the market, operating under the brand name Melaseq Chemical pathology Cardiac testing services Histopathology & cytopathology Veterinary pathology Illustrative Illustrative 40 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

41. 5.1.1 Australian Clinical Labs(continued) Subsidiaries Major Brands Major Divisions ▪ Since 2008, Helix Pathology has been providing specialized histopathology and cytology testing services to the Gold Coast region, spanning from the Northern Gold Coast to Tweed Heads ▪ Southern Sun stands as the largest specialized skin cancer laboratory in Australia and holds the distinction of being the initial commercial laboratory in the country to incorporate digital scanning into its operations Illustrative Illustrative 41 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

42. 5.1.1 Australian Clinical Labs(continued) Important Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers SunDoctors is a dedicated organization focused on diagnosing and treating skin cancer through efficient, doctor-led procedures, supported by top-notch facilities and equipment ▪ Acquisition May, 2021 - Illustrative Illustrative 42 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

43. 5.1.1 Australian Clinical Labs(continued) Revenues ($Bn), 2020-2030 $977.9 Mn was the revenue generated by Australian Clinical Labs in 2022 ▪ They are profitable in a wide range of laboratory testing services including routine and specialty tests in areas such as hematology, clinical chemistry, immunology, molecular diagnostics and genetics ▪ 70.9 70.3 63.3 Revenue generated by Dynacare in 2020 reflects the company's continued growth and success in the healthcare industry ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F Breakdown of Net Revenue by Segment, 2022 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 1 2 3 4 Illustrative Illustrative 43 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

44. 5.1.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for clinical diagnostics Recent Activity / Press Coverage Drugs Indications Illustrative Illustrative 44 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

45. 5.1.2 Company 2 (continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners Illustrative Illustrative 45 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

46. 5.1.2 Company 2 (continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers Illustrative Illustrative 46 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

47. 5.1.2 Company 2 (continued) Revenues ($Bn), 2020-2030 Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 47 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

48. Australia Healthcare Diagnostics Market Analysis 6. Reimbursement Scenario

49. 6.1 Reimbursement Regulation Medicare and Medicaid together provide health insurance coverage for more than 4 in 10 Australians The reimbursement scenario in the Australia Healthcare Diagnostics Market is complex and can vary depending on the specific treatment, setting of care, and insurance coverage. Here are some key points to consider: Medicare: o ▪ Medicare is a federal health insurance program for people aged 65 and older, as well as people with certain disabilities or health conditions Medicare covers many clinical diagnostics treatments, including chemotherapy, radiation therapy, and some immunotherapies However, coverage can be subject to strict guidelines and restrictions, such as the requirement for prior authorization Medicaid: o Medicaid is a joint federal-state program that provides health insurance for people with low incomes o Medicaid coverage for clinical diagnostics treatments can vary by state, and may be subject to limits on the amount and type of treatment covered Private Insurance: o Private insurance coverage for clinical diagnostics treatments can also vary widely depending on the insurer and the specific policy o Some policies may have high out-of-pocket costs, such as deductibles and co-pays, while others may have more comprehensive coverage Other Public 1% o Other Private 3% Uninsured 9% Medicare 17% o ▪ Medicaid and CHIP 21% ▪ Employer-Sponsored 49% Health Insurance Coverage, 2022 Illustrative Illustrative 49 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential

50. 6.1 Reimbursement Regulation (continued) Affordable Care Act: Affordable Care Act (ACA) includes provisions to help improve access to clinical diagnostics treatments by requiring insurers to cover certain preventive services, including clinical diagnostics screenings, without co-pays or deductibles It also includes protections for people with pre-existing conditions, such as clinical diagnostics Reimbursement for New Treatments: Reimbursement for new clinical diagnostics treatments can be a complex and lengthy process, as insurers and government programs often require evidence of safety and effectiveness before providing coverage This can create challenges for companies developing and marketing new treatments Value-Based Care: There is a growing trend towards value-based care, which aims to improve outcomes and lower costs by focusing on the value of treatments rather than simply the volume of treatments Value-based care models can include payment models that tie reimbursement to outcomes or performance metrics ▪ o o ▪ o o ▪ o o In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative Illustrative 50 A Sample Report on Australia Healthcare Diagnostics Market Analysis I Confidential